Donald W Kufe (Donald Kufe)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 53

Top Topics

Transcription Factor

Top Venues

International journal of molecular sciences

Cancer research communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Keyi Wang, Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon, Ayako Nakashoji, Hiroki Ozawa, Bo Peng, Wei Li, Donald W Kufe
XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression. Cell death & disease 15 (5) (2024)
Keyi Wang, Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon, Ayako Nakashoji, Hiroki Ozawa, Bo Peng, Wei Li, Donald W Kufe
XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression. Cell death & disease 15 (5) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS. Cancer research communications (2024)
Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Naoki Haratake, Ayako Nakashoji, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Takeo Kosaka, Mototsugu Oya, Donald W Kufe
MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells. Cell death discovery 10 (1) (2024)
Atrayee Bhattacharya, Keyi Wang, Johany Penailillo, Chi Ngai Chan, Atsushi Fushimi, Nami Yamashita, Tatsuaki Daimon, Naoki Haratake, Hiroki Ozawa, Ayako Nakashoji, Keisuke Shigeta, Yoshihiro Morimoto, Masaaki Miyo, Donald W Kufe
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression. Oncogene 43 (28) (2024)
Atrayee Bhattacharya, Keyi Wang, Johany Penailillo, Chi Ngai Chan, Atsushi Fushimi, Nami Yamashita, Tatsuaki Daimon, Naoki Haratake, Hiroki Ozawa, Ayako Nakashoji, Keisuke Shigeta, Yoshihiro Morimoto, Masaaki Miyo, Donald W Kufe
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression. Oncogene 43 (28) (2024)
Atrayee Bhattacharya, Keyi Wang, Johany Penailillo, Chi Ngai Chan, Atsushi Fushimi, Nami Yamashita, Tatsuaki Daimon, Naoki Haratake, Hiroki Ozawa, Ayako Nakashoji, Keisuke Shigeta, Yoshihiro Morimoto, Masaaki Miyo, Donald W Kufe
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression. Oncogene 43 (28) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. Cancer research communications 4 (5) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. Cancer research communications 4 (5) (2024)
Hiroki Ozawa, Naoki Haratake, Ayako Nakashoji, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Keisuke Shigeta, Atsushi Fushimi, Kazumasa Fukuda, Yohei Masugi, Ryo Yamaguchi, Minoru Kitago, Hirofumi Kawakubo, Yuko Kitagawa, Donald W Kufe
MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer. Biomedicines 12 (7) (2024)
Keyi Wang, Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon, Ayako Nakashoji, Hiroki Ozawa, Bo Peng, Wei Li, Donald W Kufe
XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression. Cell death & disease 15 (5) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS. Cancer research communications (2024)
Atrayee Bhattacharya, Keyi Wang, Johany Penailillo, Chi Ngai Chan, Atsushi Fushimi, Nami Yamashita, Tatsuaki Daimon, Naoki Haratake, Hiroki Ozawa, Ayako Nakashoji, Keisuke Shigeta, Yoshihiro Morimoto, Masaaki Miyo, Donald W Kufe
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression. Oncogene (2024)
Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Naoki Haratake, Ayako Nakashoji, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Takeo Kosaka, Mototsugu Oya, Donald W Kufe
MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells. Cell death discovery 10 (1) (2024)
Keyi Wang, Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon, Ayako Nakashoji, Hiroki Ozawa, Bo Peng, Wei Li, Donald W Kufe
XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression. Cell death & disease 15 (5) (2024)
Atrayee Bhattacharya, Keyi Wang, Johany Penailillo, Chi Ngai Chan, Atsushi Fushimi, Nami Yamashita, Tatsuaki Daimon, Naoki Haratake, Hiroki Ozawa, Ayako Nakashoji, Keisuke Shigeta, Yoshihiro Morimoto, Masaaki Miyo, Donald W Kufe
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression. Oncogene 43 (28) (2024)
Hiroki Ozawa, Naoki Haratake, Ayako Nakashoji, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Keisuke Shigeta, Atsushi Fushimi, Kazumasa Fukuda, Yohei Masugi, Ryo Yamaguchi, Minoru Kitago, Hirofumi Kawakubo, Yuko Kitagawa, Donald W Kufe
MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer. Biomedicines 12 (7) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. Cancer research communications 4 (5) (2024)
Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Naoki Haratake, Ayako Nakashoji, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Takeo Kosaka, Mototsugu Oya, Donald W Kufe
MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells. Cell death discovery 10 (1) (2024)
Hiroki Ozawa, Naoki Haratake, Ayako Nakashoji, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Keisuke Shigeta, Atsushi Fushimi, Kazumasa Fukuda, Yohei Masugi, Ryo Yamaguchi, Minoru Kitago, Hirofumi Kawakubo, Yuko Kitagawa, Donald W Kufe
MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer. Biomedicines 12 (7) (2024)
Victor Adorno Febles, Yuan Hao, Aarif Ahsan, Jiansheng Wu, Yingzhi Qian, Hua Zhong, Stacy Loeb, Danil V Makarov, Herbert Lepor, James Wysock, Samir S Taneja, William C Huang, Daniel J Becker, Arjun V Balar, Jonathan Melamed, Fang-Ming Deng, Qinghu Ren, Donald W Kufe, Kwok-Kin Wong, Dennis O Adeegbe, Jiehui Deng, David R Wise
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile. The Prostate (2023)
Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine Mitsiades, Donald W Kufe
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. Journal for immunotherapy of cancer 11 (2) (2023)
Donald W Kufe
Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Donald W Kufe
Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Donald W Kufe
Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Donald W Kufe
Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Atrayee Bhattacharya, Atsushi Fushimi, Keyi Wang, Nami Yamashita, Yoshihiro Morimoto, Satoshi Ishikawa, Tatsuaki Daimon, Tao Liu, Song Liu, Mark D Long, Donald W Kufe
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression. Communications biology 6 (1) (2023)
Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine Mitsiades, Donald W Kufe
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. Journal for immunotherapy of cancer 11 (2) (2023)
Donald W Kufe
Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine Mitsiades, Donald W Kufe
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. Journal for immunotherapy of cancer 11 (2) (2023)
Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine Mitsiades, Donald W Kufe
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. Journal for immunotherapy of cancer 11 (2) (2023)
Yoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, Masayuki Hagiwara, Atrayee Bhattacharya, Jingwei Cheng, Thomas C Frost, Rehan Ahmad, Tatsuaki Daimon, Lei Huang, Tsuyoshi Hata, Hidekazu Takahashi, Masaaki Yamamoto, Yozo Suzuki, James A Decaprio, Donald W Kufe
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment. Oncogene 41 (27) (2022)
Masayuki Hagiwara, Atsushi Fushimi, Atrayee Bhattacharya, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Oya, Henry G Withers, Qiang Hu, Tao Liu, Song Liu, Kwok-Kin Wong, Mark D Long, Donald W Kufe
MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. Oncoimmunology 11 (1) (2022)
Atrayee Bhattacharya, Atsushi Fushimi, Nami Yamashita, Masayuki Hagiwara, Yoshihiro Morimoto, Hasan Rajabi, Mark D Long, Maha Abdulla, Rehan Ahmad, Kelly Street, Song Liu, Tao Liu, Donald W Kufe
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells. Molecular cancer research : MCR 20 (4) (2022)
Atsushi Fushimi, Yoshihiro Morimoto, Satoshi Ishikawa, Nami Yamashita, Atrayee Bhattacharya, Tatsuaki Daimon, Hasan Rajabi, Caining Jin, Masayuki Hagiwara, Yota Yasumizu, Zhou Luan, Wenhao Suo, Kwok-Kin Wong, Henry G Withers, Song Liu, Mark D Long, Donald W Kufe
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer. Molecular cancer research : MCR 20 (9) (2022)
Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, Rehan Ahmad, Atrayee Bhattacharya, Tatsuaki Daimon, Naoki Haratake, Yuka Inoue, Satoshi Ishikawa, Masaaki Yamamoto, Tsuyoshi Hata, Sayuri Akiyoshi, Qiang Hu, Tao Liu, Henry G Withers, Song Liu, Geoffrey I Shapiro, Tomoharu Yoshizumi, Mark D Long, Donald W Kufe
MUC1-C Dictates PBRM1-Mediate Chronic Induction of Interferon Signaling, DNA Damage Resistance and Immunosuppression in Triple-Negative Breast Cancer. Molecular cancer research : MCR (2022)
Donald W Kufe
Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia. Cancers 14 (19) (2022)
Nami Yamashita, Donald W Kufe
Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression. International journal of molecular sciences 23 (15) (2022)
Nami Yamashita, Atsushi Fushimi, Yoshihiro Morimoto, Atrayee Bhattacharya, Masayuki Hagiwara, Masaaki Yamamoto, Tsuyoshi Hata, Geoffrey I Shapiro, Mark D Long, Song Liu, Donald W Kufe
Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer. Cancers 14 (11) (2022)
Nami Yamashita, Mark Long, Atsushi Fushimi, Masaaki Yamamoto, Tsuyoshi Hata, Masayuki Hagiwara, Atrayee Bhattacharya, Qiang Hu, Kwok-Kin Wong, Song Liu, Donald W Kufe
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer. Journal for immunotherapy of cancer 9 (1) (2021)
Masayuki Hagiwara, Atsushi Fushimi, Nami Yamashita, Atrayee Bhattacharya, Hasan Rajabi, Mark D Long, Yota Yasumizu, Mototsugu Oya, Song Liu, Donald W Kufe
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells. Oncogene 40 (30) (2021)
Zhou Luan, Yoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, Wenhao Suo, Atrayee Bhattacharya, Masayuki Hagiwara, Caining Jin, Donald W Kufe
MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas. Carcinogenesis (2021)
Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean Pitroda, Mark D Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu, Nami Yamashita, Atsushi Fushimi, Ling Kui, Mehmet Samur, Masaaki Yamamoto, Yan Zhang, Ning Zhang, Deli Hong, Takahiro Maeda, Takeo Kosaka, Kwok-Kin Wong, Mototsugu Oya, Donald W Kufe
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nature communications 11 (1) (2020)
Masayuki Hagiwara, Yota Yasumizu, Nami Yamashita, Hasan Rajabi, Atsushi Fushimi, Mark D Long, Wei Li, Atrayee Bhattacharya, Rehan Ahmad, Mototsugu Oya, Song Liu, Donald W Kufe
MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells. Cancer research 81 (4) (2020)
Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean Pitroda, Mark D Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu, Nami Yamashita, Atsushi Fushimi, Ling Kui, Mehmet Samur, Masaaki Yamamoto, Yan Zhang, Ning Zhang, Deli Hong, Takahiro Maeda, Takeo Kosaka, Kwok-Kin Wong, Mototsugu Oya, Donald W Kufe
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nature communications 11 (1) (2020)
Tsuyoshi Hata, Hasan Rajabi, Masaaki Yamamoto, Caining Jin, Rehan Ahmad, Yan Zhang, Ling Kui, Wei Li, Yota Yasumizu, Deli Hong, Masaaki Miyo, Masayuki Hiraki, Takahiro Maeda, Yozo Suzuki, Hidekazu Takahashi, Mehmet Samur, Donald W Kufe
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer. Molecular cancer therapeutics 18 (10) (2019)
Tsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, Yota Yasumizu, Wei Li, Caining Jin, Mark D Long, Qiang Hu, Song Liu, Atsushi Fushimi, Nami Yamashita, Ling Kui, Deli Hong, Masaaki Yamamoto, Masaaki Miyo, Masayuki Hiraki, Takahiro Maeda, Yozo Suzuki, Mehmet K Samur, Donald W Kufe
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells. Cancer research 79 (22) (2019)
Masaaki Yamamoto, Caining Jin, Tsuyoshi Hata, Yota Yasumizu, Yan Zhang, Deli Hong, Takahiro Maeda, Masaaki Miyo, Masayuki Hiraki, Yozo Suzuki, Kunihiko Hinohara, Hasan Rajabi, Donald W Kufe
MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells. Cancer research 79 (8) (2019)
Hasan Rajabi, Tsuyoshi Hata, Wei Li, Mark D Long, Qiang Hu, Song Liu, Deepak Raina, Ling Kui, Yota Yasumizu, Deli Hong, Mehmet Samur, Donald W Kufe
MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells. Oncogene 38 (47) (2019)
Hasan Rajabi, Masayuki Hiraki, Donald W Kufe
MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells. Oncogene 37 (16) (2018)
Masayuki Hiraki, Takahiro Maeda, Neha Mehrotra, Caining Jin, Maroof Alam, Audrey Bouillez, Tsuyoshi Hata, Ashujit Tagde, Amy Keating, Surender Kharbanda, Harpal Singh, Donald W Kufe
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer. Signal transduction and targeted therapy 3 (2018)
Li Yin, Ashujit Tagde, Reddy Gali, Yu-Tzu Tai, Teru Hideshima, Kenneth Anderson, David Avigan, Donald W Kufe
MUC1-C is a target in lenalidomide resistant multiple myeloma. British journal of haematology 178 (6) (2017)
Hasan Rajabi, Masayuki Hiraki, Ashujit Tagde, Maroof Alam, Audrey Bouillez, Camilla L Christensen, Mehmet Samur, Kwok-Kin Wong, Donald W Kufe
MUC1-C activates EZH2 expression and function in human cancer cells. Scientific reports 7 (1) (2017)